General Information of the Compound
| Compound ID |
CP0408770
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[5-[(4aR,8aS)-3-cycloheptyl-4-oxo-4a,5,8,8a-tetrahydrophthalazin-1-yl]-2-methoxyphenyl]-N-[2-(2-methoxyethylamino)-2-oxoethyl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H42N4O5
|
||||||||||||||||||
| Molecular Weight |
586.733
|
||||||||||||||||||
| Canonical SMILES |
COCCNC(=O)CNC(=O)c1ccc(cc1)-c1cc(ccc1OC)C1=NN(C2CCCCCC2)C(=O)[C@@H]2CC=CC[C@H]12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H42N4O5/c1-42-20-19-35-31(39)22-36-33(40)24-15-13-23(14-16-24)29-21-25(17-18-30(29)43-2)32-27-11-7-8-12-28(27)34(41)38(37-32)26-9-5-3-4-6-10-26/h7-8,13-18,21,26-28H,3-6,9-12,19-20,22H2,1-2H3,(H,35,39)(H,36,40)/t27-,28+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DBHFVQGNVFHCEF-WUFINQPMSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01305, 3',5'-cyclic-AMP phosphodiesterase 4B
Protein ID: PT00212, Phosphodiesterase